1. 106261-49-8
2. 4-((4-methylpiperazin-1-yl)methyl)benzoic Acid Dihydrochloride
3. 4-(4-methylpiperazinomethyl)benzoic Acid Dihydrochloride
4. 4-[(4-methyl-1-piperazinyl)methyl]benzoic Acid Dihydrochloride
5. Dj6e7rg2d9
6. 4-[(4-methylpiperazin-1-yl)methyl]benzoic Acid;dihydrochloride
7. Mfcd07772867
8. Benzoic Acid, 4-[(4-methyl-1-piperazinyl)methyl]-, Dihydrochloride
9. 4-(4-methylpiperazinomethyl)benzoic Acid, Dihydrochloride
10. 4-[(4-methyl-1-piperazinyl)methyl]-, Hydrochloride (1:2)
11. 4-((4-methyl-1-piperazinyl)methyl)benzoic Acid Dihydrochloride
12. Benzoic Acid, 4-((4-methyl-1-piperazinyl)methyl)-, Dihydrochloride
13. Benzoic Acid, 4-((4-methyl-1-piperazinyl)methyl)-, Hydrochloride (1:2)
14. Unii-dj6e7rg2d9
15. Ec 600-728-4
16. Schembl846616
17. Dtxsid00438349
18. 4-((4-methyl-1-piperazinyl)methyl)-benzoic Acid Dihydrochloride
19. 4-(4-methyl-piperazin-1-ylmethyl)-benzoic Acid Dihydrochloride
20. Act04892
21. Akos008030888
22. Ac-2149
23. Ac-6913
24. Cs-w012082
25. Gs-4344
26. Sb14847
27. 112gi009
28. Sy007706
29. Db-011262
30. Am20061169
31. Ft-0650480
32. M2110
33. En300-43900
34. 61m498
35. A801404
36. 4-((4-methyl-1-piperaziny)methyl)benzoic Acid 2hcl
37. 4-(4-methyl-piperazinomethyl)benzoic Acid Dihydrochloride
38. 4-(4-methylpiperzin-1-ylmethyl)benzoic Acid Dihydrochloride
39. 4-(4-methylpiperazin-1-ylmethyl) Benzoic Acid Dihydrochloride
40. 4-(4-methylpiperazin-1-ylmethyl)benzoic Acid Dihydrochloride
41. 4-[(4-methylpiperazin-1-yl)methyl]benzoic Acid 2hcl
42. 4-[(4-methylpiperazin-1-yl)methyl]benzoicaciddihydrochloride
43. Dihydrochloride 4-(4-methyl-piperazin-1-ylmethyl)-benzoic Acid
44. 4-((4-methylpiperazinyl)methyl)benzoic Acid Dihydrochloride
45. 4-[(4-methyl-1-piperazinyl)-methyl]-benzoic Acid Dihydrochloride
46. 4-[(4-methylpiperazin-1-yl) Methyl]benzoic Acid Dihydrochloride
47. 4-[(4-methylpiperazin-1-yl)methyl]-benzoic Acid Dihydrochloride
48. 4-[(4-methylpiperazin-1-yl)methyl]benzoic Acid Hydrate Dihydrochloride
| Molecular Weight | 307.21 g/mol |
|---|---|
| Molecular Formula | C13H20Cl2N2O2 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 306.0901833 g/mol |
| Monoisotopic Mass | 306.0901833 g/mol |
| Topological Polar Surface Area | 43.8 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 254 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
BUILDING BLOCK
SUPPLIERS
Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.
4-(4-Methyl Piperazino Methyl) Benzoic Acid Dihydr...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hyderabad unit specializes in a...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dih...
CAS Number : 106261-49-8-
End Use API :
End Use API : Imatinib Mesylate
About the Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-growth therapeutic areas. ...
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dih...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Anhui Haikang Pharmaceutical Co., Ltd. was established in 2009 and located in a High-tech industry park, Anqing City, Anhui Province---a famous historical and cultural city in China, ad...
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid d...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients who are looking for manuf...
BENZOIC ACID, 4-[4-METHYL-1- PIPERAZINYL) METHYL] ...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Dasami Lab Private Limited incorporated with MCA on 24 July 2015. The Dasami Lab Private Limited is listed in the class of pvtltd company and classified as Non Govt Company. This compan...
4-((4-Methylpiperazin-1-yl)methyl)benzoic acid dih...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : The Company was incorporated on 19.02.1993 to carry on the business of manufacturing of bulk drugs viz. Omeprazole,Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, etc., ha...
4-[(4-Methylpiperozin-1-yl]methyl]benzoic acid dih...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Founded in 1986, Kekule has developed from a manufacturer of few molecules to a preferred vendor for many complex molecules requiring multistage synthesis. Working with customers across...
4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dih...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients and intermediate chemicals for generic pharmaceutical companies. Our Development T...
4-((4-methylpiperazin-1-yl)methyl)benzoic acid dih...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emph...
4-[(4-methyl-1-piperaziny)methyl] benzoic acid dih...
CAS Number : 106261-49-8
End Use API :
End Use API : Imatinib Mesylate
About the Company : Riddhesh Pharmachem is a contract research and contract manufacturer from India. It has developed a service-oriented system that has allowed it to become a leading manufacturer and supp...
END USE APIs
RELATED INTERMEDIATES
